These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 18556452)
1. Successful use of rituximab in a patient with recalcitrant livedoid vasculopathy. Zeni P; Finger E; Scheinberg MA Ann Rheum Dis; 2008 Jul; 67(7):1055-6. PubMed ID: 18556452 [No Abstract] [Full Text] [Related]
2. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis. Hellmann M; Jung N; Owczarczyk K; Hallek M; Rubbert A Rheumatology (Oxford); 2008 Jun; 47(6):929-30. PubMed ID: 18411212 [No Abstract] [Full Text] [Related]
3. Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome. Kaushik VV; Reddy HV; Bucknall RC Ann Rheum Dis; 2006 Aug; 65(8):1116-7. PubMed ID: 16837496 [No Abstract] [Full Text] [Related]
5. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies]. Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of Sjogren's syndrome with rituximab. Touma Z; Sayad J; Arayssi T Scand J Rheumatol; 2006; 35(4):323-5. PubMed ID: 16882600 [No Abstract] [Full Text] [Related]
7. Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome. Salama A; Schneider U; Dörner T Ann Rheum Dis; 2008 Jun; 67(6):894-5. PubMed ID: 18474659 [No Abstract] [Full Text] [Related]
8. Treatment of livedoid vasculopathy with short-cycle intravenous immunoglobulins. Pitarch G; Rodríguez-Serna M; Torrijos A; Oliver V; Fortea JM Acta Derm Venereol; 2005; 85(4):374-5. PubMed ID: 16191872 [No Abstract] [Full Text] [Related]
9. Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab. McGonagle D; Tan AL; Madden J; Rawstron AC; Rehman A; Emery P; Thomas S Rheumatology (Oxford); 2008 Apr; 47(4):552-3. PubMed ID: 18281368 [No Abstract] [Full Text] [Related]
10. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744 [No Abstract] [Full Text] [Related]
12. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Pagel JM; Lionberger J; Gopal AK; Sabath DE; Loeb K Am J Hematol; 2007 Dec; 82(12):1121-2. PubMed ID: 17696200 [No Abstract] [Full Text] [Related]
13. Successful treatment with rituximab of autoimmune haemolytic anaemia causing dialysis-dependent acute renal failure. Brown CE; Traynor JP; Sharp RA; Fox JG Nephrol Dial Transplant; 2007 Sep; 22(9):2730-1. PubMed ID: 17575312 [No Abstract] [Full Text] [Related]
14. Refractory severe connective tissue disease thrombocytopenia: is rituximab treatment effective and safe? Zheng WJ; Zhang X; Wang Q; Xu D; Zeng XF; Zhang FC Ann Rheum Dis; 2009 Jun; 68(6):1077-8. PubMed ID: 19435726 [No Abstract] [Full Text] [Related]
15. A case of widespread livedoid vasculopathy with pain but no systemic symptoms. Okada E; Nagai Y; Ishikawa O Acta Derm Venereol; 2008; 88(3):298-9. PubMed ID: 18480943 [No Abstract] [Full Text] [Related]
16. A case of Raynaud's phenomenon in mixed connective tissue disease responding to rituximab therapy. Haroon M; O'Gradaigh D; Foley-Nolan D Rheumatology (Oxford); 2007 Apr; 46(4):718-9. PubMed ID: 17289791 [No Abstract] [Full Text] [Related]